The Committee for Medicinal Products for Human Use (CHMP) is the European Medicines Agency's (EMA) committee responsible for human medicines. It plays a vital role in the …

Dec 12, 2024 · EMA’s human medicines committee (CHMP) recommended seventeen medicines for approval at its December 2024 meeting. This brings the total number of medicines …

Jan 30, 2025 · *This product was designated as an orphan medicine during its development. Orphan designations are reviewed by EMA's Committee for Orphan Medicinal Products …

May 31, 2024 · EMA’s human medicines committee (CHMP) recommended 14 medicines for approval at its May 2024 meeting.

With the CHMP Meeting Highlights we inform you monthly about marketing authorisation recommendations for new medicinal products, new indications for already approved medicinal …

Jul 14, 2022 · At its July meeting, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended 11 medicines for approval and …

Berlin, December 13, 2024 – The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended acoramidis, a selective small …

6 days ago · PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …

Mar 2, 2023 · In its latest meeting, the Committee for Medicinal Products for Human Use (CHMP) recommended eight new medicines for approval, including an enzyme replacement therapy for …

Jul 26, 2024 · At its meeting held July 22–25, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) gave positive opinions or …